ACS management 2014: A case based approach according to new guidelines and registries
View Lectures held during symposium
View actual lectures
Educational objectivesThe goal of this program was to improve the knowledge with regard to peri- and post procedural management of ACS, based on patient cases. After attending this program, the clinician will be better able to:
- Evaluate the cardiovascular risk associated with ACS
- Describe current treatment options for ACS and assess the proportion of patients eligible for percutaneous coronary intervention (PCI)
- Describe the need for peri- and post procedural platelet inhibition
- Understand the role of platelet inhibition in clinical outcomes of patients with ACS undergoing PCI
- Describe the most important changes in ACS/PCI guidelines
- Understand the implications of real-world data from registries on ACS/PCI
ChairmenWouter Jukema, MD, Leiden University Medical Center, Leiden,The Netherlands
Jose Luis Lopez-Sendon, MD. University Hospital La Paz, Madrid, Spain
Petr Widimský, MD, Charles University, Hospital "Royal Vineyards, Prague, Czech Republic
Case 1. ACS/PCI: A patient cases based on latest guidelines
Case 2. ACS/PCI :Patient cases based on real world dataPeter Sinnaeve, MD, UZ Leuven, Leuven, Belgium
Latest guidelines on ACS/PCI: what are the key changes?Petr Widimský, MD, Charles University, Hospital "Royal Vineyards, Prague, Czech Republic
New registries on ACS/PCI: how does the real world look likePeter Sinnaeve, MD, UZ Leuven, Leuven, Belgium
Panel discussionJose Luis Lopez-Sendon, MD, University Hospital La Paz, Madrid, Spain
Julinda Mehilli, MD, LMU, Munich, Germany
Conclusions and final remarksWouter Jukema, MD
This programme is accredited by the European Board for Accreditation in Cardiology (EBAC) for 1 hour of external CME credit(s). Each participant should claim only those hours of credit that have actually been spent in the educational activity.
EBAC works according to the quality standards the European Accreditation for Continuing Medical Education (EACCME), which is an institution of the European Union of Medical Specialists (UEMS).
FundingSupported by an unrestricted educational grant from Daiichi-Sankyo, Eli Lilly and company
The content is aimed for medical professionals. To view this item member registration is needed. Register for free to get unlimited access to our educational resources.